Rubicon Genomics, Inc. Introduces PicoPlex Single Cell Whole Genome Amplification Kit for Pre-Implantation Genetic Diagnostics and Stem Cell and Cancer Cell Research

ANN ARBOR, Mich.--(BUSINESS WIRE)--Rubicon Genomics, Inc., a developer of pre-amplification products that enable optimal performance of the most advanced genetic analysis tools, announced today the release of its PicoPlex™ Single Cell Whole Genome Amplification (WGA) kit—a more rapid, accurate and reproducible method for amplifying single genomes than current technologies. This product targets the pre-implantation genetic diagnostics (PGD), cancer research and stem cell research markets, which require rapid, reproducible amplification to profile patient genotypes, karyotypes and mutations. PicoPlex enables reference labs to begin qPCR, microarray or sequencing analysis less than three hours after collecting patient cells.